Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6132
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 14 II
0167314 EU/1/09/583/038 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 15 II
0167315 EU/1/09/583/039 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 20 II
0167316 EU/1/09/583/040 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 28 II
0167317 EU/1/09/583/041 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 30 II
0167318 EU/1/09/583/042 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 56 II
0167319 EU/1/09/583/043 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 60 II
0167320 EU/1/09/583/044 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 90 II
0167321 EU/1/09/583/045 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 84 I
0194130 EU/1/09/583/073 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 84 I
0194131 EU/1/09/583/074 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 84 I
0194132 EU/1/09/583/075 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 28 KAL I
0194133 EU/1/09/583/076 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 28 KAL I
0194134 EU/1/09/583/077 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 28 KAL I
0194135 EU/1/09/583/078 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 98 II
0167322 EU/1/09/583/046 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 100 II
0167323 EU/1/09/583/047 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 50X1 II
0167324 EU/1/09/583/048 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 7 I
0167325 EU/1/09/583/049 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 14 I
0167326 EU/1/09/583/050 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 15 I
0167327 EU/1/09/583/051 irbesartan.pdf irbesartan.pdf C09DA04 R

‹‹ ‹ 50 60 70 80 90 96 97 98 99 100 101 102 103 104 105 106 110 120 130 140 150 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 25. January 2022 at 00:10
Last update of price and payment data: 1. January 2022 at 00:11